Search for: "AstraZeneca Inc."
Results 101 - 120
of 340
Sort by Relevance
|
Sort by Date
3 May 2014, 8:56 am
Pfizer, Inc., 196 F. [read post]
23 Apr 2014, 7:44 am
” See also AstraZeneca LP v. [read post]
6 Mar 2014, 12:41 pm
Pfizer, Inc., 490 F. [read post]
3 Feb 2014, 7:11 pm
Hanmi USA, Inc., No. 2013-1490 (Fed. [read post]
30 Dec 2013, 8:50 pm
Noonan -- A classic example of product "evergreening" is how AstraZeneca used its experience with its omeprazole franchise (sold for over a decade as Prilosec®) to promote an alternative form of the drug, Nexium® (particularly, the S-omeprazole enantiomer) as "the little purple pill." [read post]
19 Dec 2013, 8:56 pm
Indus., Inc., 199 F.3d 1295, 1302 (Fed. [read post]
8 Dec 2013, 8:02 pm
Kremers Urban Pharmaceuticals, Inc. et al. 3:13-cv-07299; filed December 3, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI Inc.; KBI-E Inc. [read post]
13 Nov 2013, 9:14 pm
The panel also affirmed the District Court's dismissal of invalidity counterclaims brought by Defendants-Cross Appellants Apotex, Inc. and Apotex Corp., and the lower court's decisions regarding the bond amount. [read post]
27 Oct 2013, 9:55 pm
Reddy's Laboratories Inc. et al. 3:13-cv-06157; filed October 23, 2013 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; KBI-E Inc.; Pozen, Inc.; Astrazeneca LP • Defendants: Dr. [read post]
25 Oct 2013, 3:56 am
In the court’s view, this circumstantial evidence of a “pattern of antagonism” raised an inference of retaliation and was enough to support her Title VII claim (Brangman v AstraZeneca, LP). [read post]
19 Sep 2013, 9:53 am
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
14 Aug 2013, 1:57 pm
Bard, Inc., 2006 WL 6225071 (D.D.C. [read post]
12 Aug 2013, 10:02 pm
Atkins Foundation, the Ann Arbor Area Community Foundation, the Allen Foundation, AstraZeneca, HealthCare Foundation, Borders Inc, and the Robert Beard Foundation. [read post]
1 Aug 2013, 9:29 am
The generic and brand names of the drugs in this family include: • Exenatide (Byetta & Bydureon) marketed by Bristol Myers-Squibb and Amylin Pharmaceuticals, Inc. [read post]
28 Jul 2013, 9:29 am
Byetta, now sold by Bristol-Myers Squibb and AstraZeneca, was approved in 2005 and contained a warning about pancreatitis. [read post]
24 Mar 2013, 8:01 pm
Watson Laboratories, Inc. - Florida et al. 3:13-cv-01669; filed March 19, 2013 in the District Court of New Jersey • Plaintiffs: AstraZeneca AB; Aktiebolaget Hassle; AstraZeneca LP; KBI Inc.; KBI-E Inc. [read post]
27 Feb 2013, 9:53 pm
Sandoz Inc., No. 12-3289 (D.N.J. 2013) by Katherine H. [read post]
20 Dec 2012, 12:20 pm
Apotex Corp. is a United States affiliate of the Canadian Company Apotex Inc. [read post]
30 Nov 2012, 7:45 am
Watson Laboratories, Inc. [read post]
29 Nov 2012, 5:21 am
AstraZeneca UK Limited v. [read post]
